Literature DB >> 12762352

Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation.

D Shusterman1, J Balmes, P C Avila, M A Murphy, E Matovinovic.   

Abstract

Seasonal allergic rhinitic (SAR) subjects are more sensitive to nasal irritants than nonrhinitic (NR) subjects; however, the mechanism underlying this difference is unclear. This study sought to determine whether irritant-induced nasal congestion involves mast cell degranulation. Eight SAR and eight NR subjects were exposed to both 1.0 parts per million chlorine and filtered air in separate visits; exposures were via nasal mask and lasted 15 min. Rhinomanometry was performed before, immediately after and 15 min after exposure. Following > or = 2 weeks, exposures and symptom reporting were repeated with nasal lavage, rather than rhinomanometry, pre- and postexposure. A separate substudy using rye grass antigen provided a positive control. Mast cell tryptase was measured in nasal lavage fluid from both substudies using an automated fluoroenzyme immunoassay. Chlorine provocation significantly increased nasal airway resistance in SAR but not NR subjects. Conversely, tryptase levels in nasal lavage fluid were unaffected. Nasal allergen challenge significantly increased both nasal obstruction and nasal lavage tryptase in SAR subjects. Irritant-induced nasal congestion is more pronounced among seasonal allergic rhinitic than nonrhinitic subjects. However, unlike nasal allergen challenge, the mechanism of response to chlorine does not appear to involve mast cell degranulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762352     DOI: 10.1183/09031936.03.00049102

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  TRPA1 is a major oxidant sensor in murine airway sensory neurons.

Authors:  Bret F Bessac; Michael Sivula; Christian A von Hehn; Jasmine Escalera; Lauren Cohn; Sven-Eric Jordt
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 2.  Toxicology of nasal irritants.

Authors:  Dennis Shusterman
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

3.  Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube®: a randomized clinical trial.

Authors:  Paul J Gomes; Mark B Abelson; Linda Stein; Erik Viirre; J Ernest Villafranca; Elliott C Lasser
Journal:  J Asthma Allergy       Date:  2019-03-01

Review 4.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.